Agfa-Gevaert: Cancellation of treasury shares – regulated information
30 Marzo 2022 - 9:40AM
Agfa-Gevaert: Cancellation of treasury shares – regulated
information
Mortsel, Belgium – March 30, 2022 – 5:40
p.m. CET
Notification pursuant to Article 15 of the
Act of 2 May 2007 concerning the disclosure of significant
participations in issuers whose shares are admitted to trading on a
regulated market
As a result of the decision of the Board of
Directors on March 9, 2021, the company, by notarial deed dated
March 30, 2022, cancelled a total of 2,299,218 treasury shares.
This decision was taken in accordance with the authorization
granted to the Board of Directors by the Extraordinary General
Meeting of Shareholders on May 12, 2020.
The new data concerning the company's shares and
capital following this
transaction is as follows:
Old number of outstanding shares: 160,506,706
Number of cancelled shares: 2,299,218
New number of outstanding shares (denominator):
158,207,488
Share capital: 186,794,611.00 Euro
Total number of voting rights: 158,207,488
Total number of voting securities: 158,207,488
Total number of shares without voting rights:
0
About Agfa
The Agfa-Gevaert Group is a leading company in
imaging technology and IT solutions with over 150 years of
experience. The Group holds four divisions: Radiology Solutions,
HealthCare IT, Digital Print & Chemicals and Offset Solutions.
They develop, manufacture and market analogue and digital systems
for the healthcare sector, for specific industrial applications and
for the printing industry. In 2021, the Group realized a turnover
of 1,760 million Euro.
Contact:
Viviane Dictus Director Corporate
Communication T +32 (0) 3 444 71 24 E viviane.dictus@agfa.com
Johan Jacobs
Corporate Press Relations Manager T +32 (0)3/444
80 15E johan.jacobs@agfa.com
AGFA Gevaert NV (EU:AGFB)
Gráfica de Acción Histórica
De Dic 2024 a Ene 2025
AGFA Gevaert NV (EU:AGFB)
Gráfica de Acción Histórica
De Ene 2024 a Ene 2025
